Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023) : A Cross-Sectional Study.

Journal:

Annals of Internal Medicine

Published:

2025-07-08

DOI:

10.7326/annals-24-03242

Affiliations:

10

Authors:

6

Go to article

Institutions	Authors	Share
University of Zurich (UZH), Switzerland	2.333333	0.39
Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland	1.333333	0.22
Brigham and Women's Hospital (BWH), United States of America (USA)	1.333333	0.22
Yale University, United States of America (USA)	0.666667	0.11
Yale New Haven Health System (YNHHS), United States of America (USA)	0.333333	0.06

Interested in Pharmacology and Pharmaceutical Sciences?